Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signaling

利用DNA损伤反应信号成像技术在小鼠胰腺癌模型中进行早期检测

阅读:2

Abstract

Despite its widespread use in oncology, the PET radiotracer (18)F-FDG is ineffective for improving early detection of pancreatic ductal adenocarcinoma (PDAC). An alternative strategy for early detection of pancreatic cancer involves visualization of high-grade pancreatic intraepithelial neoplasias (PanIN-3s), generally regarded as the noninvasive precursors of PDAC. The DNA damage response is known to be hyperactivated in late-stage PanINs. Therefore, we investigated whether the SPECT imaging agent (111)In-anti-γH2AX-TAT allows visualization of the DNA damage repair marker γH2AX in PanIN-3s in an engineered mouse model of PDAC, to facilitate early detection of PDAC. Methods: Genetically engineered KPC (KRas(LSL.G12D/+); p53(LSL.R172H/+); PdxCre) mice were imaged with (18)F-FDG and (111)In-anti-γH2AX-TAT. The presence of PanIN/PDAC as visualized by histologic examination was compared with autoradiography and immunofluorescence. Separately, the survival of KPC mice imaged with (111)In-anti-γH2AX-TAT was evaluated. Results: In KPC mouse pancreata, γH2AX expression was increased in high-grade PanINs but not in PDAC, corroborating earlier results obtained from human pancreas sections. Uptake of (111)In-anti-γH2AX-TAT, but not (111)In-IgG-TAT or (18)F-FDG, within the pancreas correlated positively with the age of KPC mice, which correlated with the number of high-grade PanINs. (111)In-anti-γH2AX-TAT localizes preferentially in high-grade PanIN lesions but not in established PDAC. Younger, non-tumor-bearing KPC mice that show uptake of (111)In-anti-γH2AX-TAT in the pancreas survive for a significantly shorter time than mice with physiologic (111)In-anti-γH2AX-TAT uptake. Conclusion:(111)In-anti-γH2AX-TAT imaging allows noninvasive detection of DNA damage repair signaling upregulation in preinvasive PanIN lesions and is a promising new tool to aid in the early detection and staging of pancreatic cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。